New Two-Pronged attack on aggressive prostate cancer

NCT ID NCT07182279

Recruiting now Disease control Sponsor: The Methodist Hospital Research Institute Source: ClinicalTrials.gov ↗

Summary

This study is testing a two-step treatment for men with high-risk prostate cancer that hasn't spread. First, patients receive a single, strong dose of targeted radiation directly to the prostate. Four to eight weeks later, they have robotic surgery to remove the prostate. Some patients with the highest-risk features will also receive a few months of hormone-blocking drugs after surgery to try to prevent the cancer from coming back. The main goals are to see if this combined approach is safe and if patients can complete the full treatment plan.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (ADENOCARCINOMA) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Houston Methodist
RECRUITING

Houston, Texas, 77030, United States

Contact

Contact

Conditions

Explore the condition pages connected to this study.

PROSTATE CANCER (ADENOCARCINOMA)